| Code | Name | Deposits | Targets | Ligand Type |
|---|---|---|---|---|
| JNK | n-{2'-[(4-fluorophenyl)amino]-4,4'-bipyridin-2-yl}-4-me thoxycyclohexanecarboxamide | 4 | 1 | biological |
| NEP | n1-phosphonohistidine | 1 | 1 | modified residue |
| MOA | mycophenolic acid | 2 | 1 | biological |
| SHL | modified comenic acid | 1 | 1 | biological |
| EMM | [methyl(vinyl)amino]methanol | 1 | 1 | crystallization |
| MOH | methanol | 2 | 1 | crystallization |
| MES | MES | 20 | 10 | crystallization |
| MES | MES | 6 | 6 | other |
| MAL | maltose | 2 | 2 | biological |
| MO6 | magnesium ion, 6 waters coordinated | 2 | 1 | crystallization |
| MG | magnesium | 31 | 26 | biological |
| MG | magnesium | 30 | 27 | other |
| MG | magnesium | 49 | 46 | crystallization |
| LTR | l-tryptophan | 1 | 1 | biological |
| NEU | l-neopterin | 1 | 1 | biological |
| LI | lithium ion | 1 | 1 | crystallization |
| LI | lithium ion | 1 | 1 | other |
| X8Z | l-captopril | 1 | 1 | biological |
| X8Z | l-captopril | 1 | 1 | crystallization |
| GPE | l-alpha-glycerophosphorylethanolamine | 1 | 1 | biological |